SciELO - Scientific Electronic Library Online

 
vol.113 número2Quiste esplénico. Esplenectomía parcial con exclusión vascular laparoscópicaParatiroidectomía transoral endoscópica por abordaje vestibular: experiencia inicial en la Argentina índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista argentina de cirugía

versão impressa ISSN 2250-639Xversão On-line ISSN 2250-639X

Rev. argent. cir. vol.113 no.2 Cap. Fed. jun. 2021

http://dx.doi.org/10.25132/raac.v113.n2.1525.ei 

Articles

Cholecystectomy and heart transplantation

Enrique J. Petracchi1  * 

Pablo A. Merchán del Hierro1 

Diego C. Chaktoura1 

Magalí Muthular1 

Nicolás F. Ba glietto1 

Carlos M. Canullán1 

1 División Cirugía General HGA Dr. Cosme Argerich. Buenos Aires. Argentina.

Introduction

The first heart transplantation was performed in 1967 and the patient survived 18 days1. The advances in perioperative care and immunosuppressive treatment resulted in a significant increase in survival of transplant patients2. This increase caused the development of transplant-related diseases, and the diagnosis and treatment of conditions that are prevalent in the general population had to be adapted to these patients.

The prevalence of gallbladder stones in transplant patients is higher than in the general population3 due to factors that promote lithogenesis, such as immunosuppressants (cyclosporine, tacrolimus), obesity, weight variations and diabetes3-6. The risk of complications associated with immunosuppressants and abnormal ventricular function complicates defining the optimal timing for cholecystectomy.

The aim of this study is to analyze and describe the results obtained in cholecystectomies in heart transplant patients.

Material and Methods

We conducted a retrospective descriptive study of heart transplant patients > 18 years who underwent laparoscopic cholecystectomy between January 1994 and December 2017 at Hospital Cosme Argerich.

We selected patients by cross-referencing the databases of heart transplantation and scheduled biliary surgeries. We identified patients with a history of transplantation and collected information on their medical history, clinical parameters and laboratory tests at the time of biliary surgery, the time interval between transplantation and cholecystectomy, indication for cholecystectomy, intraoperative cholangiography (IOC), presence of choledocholithiasis, postoperative length of stay in the intensive care unit, conversion to open surgery, postoperative complications, readmission rate and mortality.

Statistical data analysis was performed using Microsoft Excel 2010®. Qualitative variables are expressed as percentage and quantitative variables are expressed as mean ± standard deviation or median and interquartile range, according to their distribution.

An informed consent was not required due to the retrospective nature of the study.

Results

Between January 1994 and December 2017, 154 heart transplant procedures were performed (112 men and 2 women). Mean age was 40 years (30- 53). Of these patients, 16 underwent laparoscopic cholecystectomy after hear transplantation. The time interval between transplantation and cholecystectomy ranged between 4 and 180 months.

The clinical characteristics and indications for transplantation are described in Tables 1 and 2.

Table 1 Clinical history and indications for heart transplantation (n=16). 

Table 2 Characteristics of laparoscopic cholecystectomy in 16 patients with heart transplantation 

The immunosuppressants used were cyclosporine 50%, mycophenolate 33%, everolimus in 2 patients and azathioprine in 1.

All the patients corresponded to ASA (American Society of Anesthesiologists) physical status classification grade 3.

The predictors of choledocholithiasis (alkaline phosphatase and gamma glutamyl transferase) were increased in 88% of the patients.

The main indications for cholecystectomy were symptomatic cholelithiasis (38%), acute cholecystitis (47%) and bile duct obstruction (15%) diagnosed by clinical criteria, ultrasound and laboratory tests before surgery. All the patients underwent laparoscopic cholecystectomy; one patient required conversion to open surgery due to multiple adhesions.

Intraoperative cholangiography was performed in 100% of the cases, and two patients (11%) presented choledocholithiasis that was managed with transcystic instrumentation using a Dormia basket.

Six patients (37.5%) required admission to the intensive care unit after surgery with men length of stay of 1.7 days (range 0-4).

There were no postoperative complications, readmissions or mortality on the series.

Discussion

In our series, mean age was 44 years, and most patients were male (62%), as opposed to the published literature5,7. All these patients should undergo abdominal ultrasound during evaluation and follow-up to detect gallbladder stones and avoid related complications4,8,9.

In a series of 509 patients, 22% underwent cholecystectomy (13% before transplantation and 9% after transplantation)8. Although there is no consensus about the timing for performing the intervention, several studies have shown that laparoscopic cholecystectomy is safe and effective in these patients.

To our knowledge, there are no studies comparing the safety of cholecystectomy before or after transplantation. Cholecystectomy before transplantation should be considered in clinically stable patients 8,10.

All these patients should undergo abdominal ultrasound during evaluation and follow-up to detect gallbladder stones and avoid related complications4,6,11; prophylactic cholecystectomy after surgery is an option9.

The percentage of cholelithiasis in our study (11%) was lower than in other series (19.5%)5.

The immediate postoperative period after transplantation has the highest rate of morbidity and mortality; therefore, in these cases it is better to carry out a less invasive procedure (percutaneous cholecystostomy, endoscopic retrograde cholangiopancreatography, etc.) until ventricular function improves enough to allow performing cholecystectomy8.

Cholecystectomy before transplantation is difficult since most patients require acute transplantation and their ventricular function is a contraindication to cholecystectomy.

These results show that laparoscopic cholecystectomy in heart transplant patients is safe, even in cases of acute cholecystitis and choledocholithiasis. Other studies show higher rates of morbidity and mortality4,8 and one large series reported a mortality rate up to 2.2%10.

The preoperative evaluation and postoperative complications of transplant patients are similar to those of the general population.

Conclusions

The possibility of developing biliary complications leads to performing cholecystectomies in asymptomatic patients; therefore, abdominal ultrasound is recommended for the early detection of gallbladder stones.

Cholecystectomy before transplantation is difficult since most patients require acute transplantation and their ventricular function is a contraindication to cholecystectomy.

Laparoscopic cholecystectomy is safe and is the method of choice for heart transplant patients with cholelithiasis. Intraoperative cholangiography should be performed as the predictors of choledocolithiasis are usually abnormal.

Referencias bibliográficas /References

1. Roberts WC, Roberts CC, Ko JM, Filardo G, Capehart JE, Hall SA. Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incon gruence between the clinical and morphologic diagnoses. Med (United States). 2014;93(5):211-35. [ Links ]

2. Reynolds J, Cediel JF, Payán C. Christiaan Barnard: 40 años del primer transplante de corazón humano. Colomb med. 2007;38:440-2. [ Links ]

3. Gupta D, Sakorafas GH, McGregor CG, Harmsen WS, Farnell MB. Management of biliary tract disease in heart and lung transplant patients. Surgery. 2000;128(4):641-9. [ Links ]

4. Lord RVN, Ho S, Coleman MJ, Spratt PM. Cholecystectomy in cardiothoracic organ transplant recipients. Arch Surg. 1998;133(1):73-9. [ Links ]

5. Wegrzyn P, Popiolek M, Przybylowski P, Wierzbicki K, Zareba K, Milaniak I, et al. The risk of cholelithiasis in patients after heart transplantation. Arch Med Sci. 2014;10(1):53-7. [ Links ]

6. Stief J, Stempfle HU, Lehnert P, Kaiser C, Schiemann U. Biliary diseases in heart transplanted patients : a comparison between cyclosporine a versus tacrolimus - based immunosupression. Eur J Med Res. 2009; 14(5):206-9. [ Links ]

7. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroen terology. 1999;117(3):6329. [ Links ]

8. Richardson WS, Surowiec WJ, Carter KM, Howell TP, Mehra MR, Bowen JC. Gallstone Disease in Heart Transplant Recipients. Ann Surg. 2003;237(2):273-6. [ Links ]

9. Kao LS, Flowers C, Flum DR. Prophylactic cholecystectomy in transplant patients: A decision analysis. J Gastrointest Surg. 2005;9(7):965-72. [ Links ]

10. Kilic A, Sheer A, Shah AS, Russell SD, Gourin CG, Lidor AO. Out comes of cholecystectomy in US heart transplant recipients. Ann Surg . 2013;258(2):312-7. [ Links ]

11. Menegaux F, Huraux C, Jordi-Galais P, Dorent R, Ghossoub JJ, Pavie A, et al. Lithiase biliaire chez le transplante cardiaque. Ann Chir. 2000;125(9):832-7. [ Links ]

Received: June 05, 2020; Accepted: November 12, 2020

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons